Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (81-90 of 1,359) with videos related to

Pageof 136
Sort By:
Ejhaem|July 18, 2022
Concurrent follicular lymphoma and Langerhans cell sarcomaMehrnoosh Tashakori, L Jeffrey Medeiros
Ejhaem|July 18, 2022
The beginning of a new therapeutic era in acute myeloid leukemiaChristian Récher
Ejhaem|July 18, 2022
Comparison of inhibitory effects of irreversible and reversible Btk inhibitors on platelet functionBibian M E Tullemans, Mieke F A Karel, Valentine Léopold, et al.
Ejhaem|July 18, 2022
CD4<sup>+</sup> regulatory and naïve T cells specific for factor VIII stand vis-à-vis to balance the immune response in healthy individualsAnja Schmidt, Aleksander Orlowski, Emilia Salzmann-Manrique, et al.
Ejhaem|July 18, 2022
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma ForumAya Nakaya, Hirohiko Shibayama, Eiji Nakatani, et al.
Ejhaem|July 18, 2022
Mechanism of increased efficacy of recombinant Fc-μTP-L309C compared to IVIg to ameliorate mouse immune thrombocytopeniaBonnie J B Lewis, Beth Binnington, Megan Blacquiere, et al.
Ejhaem|July 18, 2022
Plasmablastic myeloma progressed to plasma cell leukaemiaKe Xu, Anna Childerhouse, Ahmed Al-Hassani, et al.
Ejhaem|July 18, 2022
An unusual case of splenic B-cell lymphoma/leukemiaMehrnoosh Tashakori, Pei Lin
Ejhaem|July 18, 2022
The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor-risk cytogenetic abnormalitiesMona Hassanein, Riad El Fakih, Walid Rasheed, et al.
Ejhaem|July 18, 2022
Widespread myeloid sarcomas in a patient in morphological remission in the bone marrowJennifer Vidler, Kate Fletcher, Sukanya Gogoi, et al.
Pageof 136

Showing results (81-90 of 1,359) with videos related to

Sort By:
Pageof 136
Ejhaem|July 18, 2022
Concurrent follicular lymphoma and Langerhans cell sarcomaMehrnoosh Tashakori, L Jeffrey Medeiros
Ejhaem|July 18, 2022
The beginning of a new therapeutic era in acute myeloid leukemiaChristian Récher
Ejhaem|July 18, 2022
Comparison of inhibitory effects of irreversible and reversible Btk inhibitors on platelet functionBibian M E Tullemans, Mieke F A Karel, Valentine Léopold, et al.
Ejhaem|July 18, 2022
CD4<sup>+</sup> regulatory and naïve T cells specific for factor VIII stand vis-à-vis to balance the immune response in healthy individualsAnja Schmidt, Aleksander Orlowski, Emilia Salzmann-Manrique, et al.
Ejhaem|July 18, 2022
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma ForumAya Nakaya, Hirohiko Shibayama, Eiji Nakatani, et al.
Ejhaem|July 18, 2022
Mechanism of increased efficacy of recombinant Fc-μTP-L309C compared to IVIg to ameliorate mouse immune thrombocytopeniaBonnie J B Lewis, Beth Binnington, Megan Blacquiere, et al.
Ejhaem|July 18, 2022
Plasmablastic myeloma progressed to plasma cell leukaemiaKe Xu, Anna Childerhouse, Ahmed Al-Hassani, et al.
Ejhaem|July 18, 2022
An unusual case of splenic B-cell lymphoma/leukemiaMehrnoosh Tashakori, Pei Lin
Ejhaem|July 18, 2022
The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor-risk cytogenetic abnormalitiesMona Hassanein, Riad El Fakih, Walid Rasheed, et al.
Ejhaem|July 18, 2022
Widespread myeloid sarcomas in a patient in morphological remission in the bone marrowJennifer Vidler, Kate Fletcher, Sukanya Gogoi, et al.
Pageof 136